Terms: = Leukemia AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Treatment
144 results:
1. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid leukemia.
Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of MYC translation through targeting of the newly identified PHB-eif4f complex as a therapeutic strategy in CLL.
Largeot A; Klapp V; Viry E; Gonder S; Fernandez Botana I; Blomme A; Benzarti M; Pierson S; Duculty C; Marttila P; Wierz M; Gargiulo E; Pagano G; An N; El Hachem N; Perez Hernandez D; Chakraborty S; Ysebaert L; François JH; Cortez Clemente S; Berchem G; Efremov DG; Dittmar G; Szpakowska M; Chevigné A; Nazarov PV; Helleday T; Close P; Meiser J; Stamatopoulos B; Désaubry L; Paggetti J; Moussay E
Blood; 2023 Jun; 141(26):3166-3183. PubMed ID: 37084385
[TBL] [Abstract] [Full Text] [Related]
3. eif4a inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
Fooks K; Galicia-Vazquez G; Gife V; Schcolnik-Cabrera A; Nouhi Z; Poon WWL; Luo V; Rys RN; Aloyz R; Orthwein A; Johnson NA; Hulea L; Mercier FE
J Exp Clin Cancer Res; 2022 Dec; 41(1):340. PubMed ID: 36482393
[TBL] [Abstract] [Full Text] [Related]
4. The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors.
Liu L; Vujovic A; Deshpande NP; Sathe S; Anande G; Chen HTT; Xu J; Minden MD; Yeo GW; Unnikrishnan A; Hope KJ; Lu Y
Nat Commun; 2022 Jul; 13(1):3833. PubMed ID: 35781533
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.
Wang Y; Zhou W; McReynolds LJ; Katki HA; Griffiths EA; Thota S; Machiela MJ; Yeager M; McCarthy P; Pasquini M; Wang J; Karaesmen E; Rizvi A; Preus L; Tang H; Wang Y; Pooler L; Sheng X; Haiman CA; Van Den Berg D; Spellman SR; Wang T; Kuxhausen M; Chanock SJ; Lee SJ; Hahn TE; Sucheston-Campbell LE; Gadalla SM
Sci Rep; 2021 Jul; 11(1):15004. PubMed ID: 34294836
[TBL] [Abstract] [Full Text] [Related]
6. Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
Jain N; Maiti A; Ravandi F; Konopleva M; Daver N; Kadia T; Pemmaraju N; Short N; Kebriaei P; Ning J; Cortes J; Jabbour E; Kantarjian H
Am J Hematol; 2021 Aug; 96(8):1000-1007. PubMed ID: 33991360
[TBL] [Abstract] [Full Text] [Related]
7. Targeting eif4f translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax.
Herzog LO; Walters B; Buono R; Lee JS; Mallya S; Fung A; Chiu H; Nguyen N; Li B; Pinkerton AB; Jackson MR; Schneider RJ; Ronai ZA; Fruman DA
Br J Cancer; 2021 Mar; 124(6):1098-1109. PubMed ID: 33318657
[TBL] [Abstract] [Full Text] [Related]
8. Parameter perturbations in a post-treatment chronic myeloid leukemia model capture the essence of pre-diagnosis A-bomb survivor mysteries.
Radivoyevitch T
Radiat Environ Biophys; 2021 Mar; 60(1):41-47. PubMed ID: 33125593
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract] [Full Text] [Related]
10. Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.
Pal I; Safari M; Jovanovic M; Bates SE; Deng C
Curr Hematol Malig Rep; 2019 Aug; 14(4):219-227. PubMed ID: 31231778
[TBL] [Abstract] [Full Text] [Related]
11. XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.
Zhu ZC; Liu JW; Yang C; Zhao M; Xiong ZQ
Cell Death Dis; 2019 May; 10(6):395. PubMed ID: 31113936
[TBL] [Abstract] [Full Text] [Related]
12. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract] [Full Text] [Related]
13. Time to Second-line treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma.
Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
[TBL] [Abstract] [Full Text] [Related]
14. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
[TBL] [Abstract] [Full Text] [Related]
15. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
Kourelis TV; Buadi FK; Gertz MA; Lacy MQ; Kumar SK; Kapoor P; Go RS; Lust JA; Hayman SR; Rajkumar V; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Leung N; Hwa YL; Gonsalves W; Kyle RA; Dispenzieri A
Leukemia; 2016 May; 30(5):1079-85. PubMed ID: 26669974
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
Gu Y; Estcourt LJ; Doree C; Hopewell S; Vyas P
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011577. PubMed ID: 26436602
[TBL] [Abstract] [Full Text] [Related]
17. Nutritional support in children and young people with cancer undergoing chemotherapy.
Ward EJ; Henry LM; Friend AJ; Wilkins S; Phillips RS
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD003298. PubMed ID: 26301790
[TBL] [Abstract] [Full Text] [Related]
18. The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
Shi F; Yang X; Gong Y; Shi R; Yang X; Naren D; Wu J
Anticancer Drugs; 2015 Apr; 26(4):410-21. PubMed ID: 25535978
[TBL] [Abstract] [Full Text] [Related]
19. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Stern A; Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391
[TBL] [Abstract] [Full Text] [Related]
20. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kourelis TV; Gertz M; Zent C; Lacy M; Kyle R; Kapoor P; Zeldenrust S; Buadi F; Witzig T; Hayman S; Lust J; Russell S; Lin Y; Rajkumar VS; Kumar S; Leung N; Dingli D; Dispenzieri A
Am J Hematol; 2013 May; 88(5):375-8. PubMed ID: 23508840
[TBL] [Abstract] [Full Text] [Related]
[Next]
